Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Comment by Jasper66on Dec 22, 2020 2:37pm
226 Views
Post# 32162365

RE:COVID testing: $22,400,000,000 available until 2022

RE:COVID testing: $22,400,000,000 available until 2022Thanks for putting so much time researching the company.  Qsc is a rock solid company that is flying under the radar.  Were going to wake up on day and see Qsc skyrocket.  We are just weeks away from tripling our monthly revenue.  At some point a large institution is going to notice.  Qsc management  team already have many connections.

I suggest everyone do there own due dilegence, however I like how you always provide the links to everything you say instead of bashers who openly admit they are shorting the stock and then provide no documentation to back up anything they say. The real kicker is how they bash and expect everyone to believe their bullshit and become irrate when no one believes them.

The stock price is where it should be, yes i would like it to be higher, based on my emotion and not on the facts.  This company was just formed in April and have moved in a short time to a company that have stared to generate millions in revenue every month.  The shorters took a risk, this stock now has a realistic huge upside potential of going north of a dolllar over heading into the teens again.

With Biden now taking the virus seriously and the money that has just been allocated, I bet Qsc is already working on deals to get some of that pie.

Qsc hasnt done a very good job before but now they are doing a much better job of sharing information with us.  I have been critical of this in the past but not now.  They are keeping us informed. Keeping Investors informed is not pumping.

So what I am trying to say is Sarb99, cause of you and your fact based posts, I have accumulated a lot of shares and your advice is going help us change our lives for the good very soon.
<< Previous
Bullboard Posts
Next >>